Invitrogen™ ATP13A2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Catalog Number	Mfr. No.	Quantity
PIPA5111322	Invitrogen™ PA5111322	100 μL
PIPA5111398	Invitrogen™ PA5111398	100 μL

Description

Immunogen sequence: EIRDKEDSSW QLFTVQVQTE AIGEGSLEPS PQSQAEDGRS QAAVGAVPEG AWKDTAQLHK SEEAVSVGQK RVLRYYLFQG QRYIWIET.

Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2, otherwise known as PARK9, is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson's disease.

Specifications

• Antigen: ATP13A2
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Classification: Polyclonal
• Form: Liquid
• Isotype: IgG
• Target Species: Human
• Gene: ATP13A2
• Gene Alias: 1110012E06Rik; AA589443; AT132 antibody; Atp13a2; ATPase 13A2; ATPase type 13A2; Cation-transporting ATPase 13A2; CLN12; HSA9947; HSA9947 antibody; KRPPD; PARK9; probable cation-transporting ATPase 13A2; putative ATPase; RGD1307977; RP1-37C10.4
• Gene Symbols: ATP13A2
• Primary or Secondary: Primary
• Purification Method: Antigen Affinity Chromatography

• Concentration: 0.40 mg/mL
• Applications: Immunohistochemistry (Paraffin)
• Conjugate: Unconjugated
• Host Species: Rabbit
• Regulatory Status: RUO
• Formulation: PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
• Gene Accession No.: Q9NQ11
• Gene ID (Entrez): 23400
• Immunogen: Recombinant Protein corresonding to Human ATP13A2. Recombinant protein control fragment (Product #RP-103955).
• Product Type: Antibody